Skip to main content
. 2017 Jul 26;8(34):57231–57245. doi: 10.18632/oncotarget.19569

Figure 4. In vivo FMT imaging of the tumor.

Figure 4

Non-invasive longitudinal imaging was performed on the whole-body at 5 min and 3, 6, 24, 48 and 96 h after injection of Ab-F conjugates in A375 xenograft bearing mice. An ROI was created around tumor to quantitate Ab uptake in tumors. (A) Representative tumor ROI images of a mouse from the Ab-AF680 group at various time points. (B) FMT quantitation for Ab uptake in the tumor (%ID) vs. time for various Ab-F conjugates. The profiles are averages from n = 5/group, with ± SEM as error bars.